Medication info

New Sendro Tablets (Sodium Alendronate Trihydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tablet
Manufacturer / importer
AhnGuk NewPharm Co., Ltd.
Appearance
White oval tablet
Packaging
For domestic use - 4 tablets/PTP[(Alu-Alu) x 1]
Approval status
Expired

MFDS item code 201901006 · Approved 2019.02.19

This product's status changed to Expired on 2024.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take alendronic acid 70 mg once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions for Use). ○ Other beverages or food, including mineral water and barley tea, and medications may decrease the absorption of this drug (see Drug Interactions). If food is consumed within 30 minutes after taking this drug or at the same time, absorption of the drug into the body may be reduced and its effect may decrease. This drug should be taken as soon as you get up in the morning and swallowed with a sufficient amount of water (170 ∼ 230 mL) to help the drug reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this drug and until after the first food intake. Do not take this drug at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions for Use). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use). ○ The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be periodically reassessed for their risk of fracture. ○ If you forget to take a dose on the scheduled day, take 70 mg the following morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
AhnGuk NewPharm Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis in postmenopausal women
  • osteoporosis in men
View approved original text

Used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

○ Take alendronic acid 70 mg once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions for Use). ○ Other beverages or food, including mineral water and barley tea, and medications may decrease the absorption of this drug (see Drug Interactions). If food is consumed within 30 minutes after taking this drug or at the same time, absorption of the drug into the body may be reduced and its effect may decrease. This drug should be taken as soon as you get up in the morning and swallowed with a sufficient amount of water (170 ∼ 230 mL) to help the drug reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this drug and until after the first food intake. Do not take this drug at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions for Use). Patients with inadequate dietary intake of calcium and vitamin D should take supplements (see Precautions for Use). ○ The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be periodically reassessed for their risk of fracture. ○ If you forget to take a dose on the scheduled day, take 70 mg the following morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. Do not take 2 tablets on the same day.

Precautions

This medication may irritate the upper gastrointestinal mucosa, so patients with esophageal conditions such as esophagitis or esophageal ulcers must be cautious while taking it. When taking this medication, it should be taken with sufficient amounts of water and the patient should not lie down for at least 30 minutes after taking it. If symptoms of esophageal issues such as dysphagia, odynophagia, pain behind the sternum, or heartburn occur, the patient must stop taking the medication immediately and consult a doctor. Patients with delayed esophageal clearance, hypocalcemia, severe renal impairment, pregnant or nursing women, and individuals with certain hereditary metabolic disorders should not take this medication. This medication should not be chewed or sucked in the mouth, and it is also advisable not to take it before bedtime or upon awakening. During treatment, adequate intake of calcium and vitamin D should be ensured, and it is advisable to maintain weight-bearing exercises and healthy lifestyle habits. Side effects such as gastrointestinal disturbances, musculoskeletal pain, headaches, dizziness, and skin rashes may occur, and any unusual symptoms should be reported to a doctor. There may be interactions with other medications, so caution is needed, especially when taken with calcium supplements, antacids, aspirin, or non-steroidal anti-inflammatory drugs. Women who are pregnant or may become pregnant, and nursing women should not take this medication, and safety in children and adolescents under 18 years has not been established. Elderly patients can take this medication, but they may be more sensitive and require caution. In case of overdose, symptoms like hypocalcemia and gastrointestinal adverse reactions may occur, therefore the prescribed dosage should be strictly followed, and immediate medical attention is necessary in case of overdose. This medication should be kept out of reach of children and it is advisable not to transfer it to other containers.

Side effects

Stimulation of the upper gastrointestinal mucosa, bleeding, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste disturbances, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, weakness, fever, symptoms of hypocalcemia, peripheral edema, oral pharyngeal ulcer, gastric ulcer, duodenal ulcer, jaw necrosis, joint swelling, low-energy fracture of the femoral neck, dizziness, itching, hair loss, mucous membrane syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, external auditory canal cholesteatoma, melena

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture, and it is best kept in a cool place at temperatures between 15 to 30 degrees. This storage method helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White oval tablet

Package unit

For domestic use - 4 tablets/PTP[(Alu-Alu) x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.